These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
775 related items for PubMed ID: 16313289
1. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians. Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT. HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289 [Abstract] [Full Text] [Related]
2. Characterization of GBV-C infection in HIV-1 infected patients. Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori G, Lazzarin A, Clementi M. J Biol Regul Homeost Agents; 2003 Jan; 17(2):191-4. PubMed ID: 14518722 [Abstract] [Full Text] [Related]
3. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, Morsica G, Pizzaferri P, Ladisa N, Sighinolfi L, Chiodera A, Solmone M, Lalle E, Ippolito G, Monforte Ad, HepaICoNA Study Group, ICoNA Study Group. Antivir Ther; 2005 Jan; 10(1):109-17. PubMed ID: 15751768 [Abstract] [Full Text] [Related]
4. Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women. Campos AF, Tengan FM, Silva SA, Levi JE. Int J STD AIDS; 2011 Apr; 22(4):209-13. PubMed ID: 21515753 [Abstract] [Full Text] [Related]
5. GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals. Li C, Collini P, Danso K, Owusu-Ofori S, Dompreh A, Candotti D, Opare-Sem O, Allain JP. AIDS; 2006 Feb 14; 20(3):379-86. PubMed ID: 16439871 [Abstract] [Full Text] [Related]
6. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients. Rodriguez B, Woolley I, Lederman MM, Zdunek D, Hess G, Valdez H. J Infect Dis; 2003 Feb 01; 187(3):504-7. PubMed ID: 12552436 [Abstract] [Full Text] [Related]
7. Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy. Alcalde R, Nishiya A, Casseb J, Inocêncio L, Fonseca LA, Duarte AJ. Virus Res; 2010 Aug 01; 151(2):148-52. PubMed ID: 20420864 [Abstract] [Full Text] [Related]
8. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes. Mootsikapun P, Chetchotisakd P, Anunnatsiri S, Boonyaprawit P. Antivir Ther; 2005 Aug 01; 10(8):911-6. PubMed ID: 16430196 [Abstract] [Full Text] [Related]
9. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy. Sheng WH, Hung CC, Wu RJ, Wang JT, Chen PJ, Chang SC, Kao JH. Clin Infect Dis; 2007 Feb 15; 44(4):584-90. PubMed ID: 17243064 [Abstract] [Full Text] [Related]
10. [GB virus C: lack of association with transaminases levels, CD4 and HIV viral load in aids patients]. López Calvo S, Vela A, Castro A, Cid A, Aguilera A, Vega P, Hermida M, Regueiro BJ, Pedreira JD. An Med Interna; 2003 Apr 15; 20(4):175-8. PubMed ID: 12768829 [Abstract] [Full Text] [Related]
11. Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART. Björkman P, Flamholc L, Molnegren V, Marshall A, Güner N, Widell A. AIDS; 2007 Jul 31; 21(12):1641-3. PubMed ID: 17630561 [Abstract] [Full Text] [Related]
12. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease. Berzsenyi MD, Bowden DS, Roberts SK, Revill PA. J Gastroenterol Hepatol; 2009 Aug 31; 24(8):1407-10. PubMed ID: 19702909 [Abstract] [Full Text] [Related]
13. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, Sherman KE, Zdunek D, Hess G, Chung RT, AIDS Clinical Trial Group A5071 Study Team. J Infect Dis; 2006 Aug 15; 194(4):410-9. PubMed ID: 16845623 [Abstract] [Full Text] [Related]
16. Infection with GB virus C and reduced mortality among HIV-infected patients. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP. N Engl J Med; 2001 Sep 06; 345(10):715-24. PubMed ID: 11547740 [Abstract] [Full Text] [Related]
17. Frequency and genotype of GB virus C among Iranian patients infected with HIV. Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M, Aghakhani A, Eslamifar A, Mahboudi F, Edalat R, Ramezani A. J Med Virol; 2008 Nov 06; 80(11):1941-6. PubMed ID: 18814233 [Abstract] [Full Text] [Related]
18. Comparative potency of three antiretroviral therapy regimes in primary HIV infection. Fidler S, Fraser C, Fox J, Tamm N, Griffin JT, Weber J. AIDS; 2006 Jan 09; 20(2):247-52. PubMed ID: 16511418 [Abstract] [Full Text] [Related]
19. No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort. Descamps D, Damond F, Bénard A, Matheron S, Campa P, Taieb A, Yahyaoui R, Chêne G, Brun-Vézinet F. AIDS; 2006 Apr 24; 20(7):1076-9. PubMed ID: 16603866 [Abstract] [Full Text] [Related]
20. Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study Cohort. Handelsman E, Cheng I, Thompson B, Hershow R, Mofenson LM, Hollinger FB, Chen KT, Burchett SK, Klinzman D, Stapleton JT, Women and Infants Transmission Study Group (WITS). HIV Med; 2007 Nov 24; 8(8):561-7. PubMed ID: 17944690 [Abstract] [Full Text] [Related] Page: [Next] [New Search]